Membership information

Our members give Emerge Australia the impetus, encouragement and drive to continue our work. By joining and supporting us, you will be helping to advance our cause to improve the lives of everyone with ME/CFS and their families. You'll also benefit by receiving our flagship quarterly journal Emerge delivered straight to your doormat or inbox as soon as it's published, and you'll be the first to know about member-only events and opportunities. Membership costs as little as $5.

Who is membership for?

We encourage anyone living with ME/CFS, their carers, family and friends, and any other supporters to become members. As our membership grows, our voice and ability to speak on your behalf grows louder.

How much does a membership cost?

Emerge Australia has two tiers of membership:

$50 (incl GST) annual membership
$5 (incl GST) annual membership (financial hardship)

Each tier gives the same benefits. Financial hardship is self-defined and does not require documentation.

What are the benefits of membership?

You will receive:

four issues of our quarterly journal, the Emerge magazine
a monthly newsletter
access to occasional member-only events

How do I become a member?

You can apply to become a member or renew your membership at any time online. If you would like assistance to complete this process, please contact the InfoLine on 03 9529 1344.

Your membership application is subject to the Membership Guidelines of the Association. In the event that your application does not comply with these guidelines, you will be advised accordingly and your membership fee will be refunded in full.

Once your membership application has been approved, it will be processed and you will receive a confirmation email, as well as a member pack in the mail. Membership processing times can be up to five working days.

Click here to sign up or renew your membership

Latest

Research Digest 21/02/20

Welcome to the 41st edition, featuring a Doppler study that confirms a reduction in cerebral blood flow in ME/CFS patients & an Australian study that looks at the levels of parasympathetic activity during sleep.
Research Digest 07/02/20

Welcome to the 40th edition, featuring an American metabolomics study of patient plasma and a study looking at the prevalence of paediatric ME/CFS in Chicago according to diverse community-based random sample.
Research Digest 24/01/20

Welcome to the 39th edition, featuring a systematic review of ME/CFS randomized controlled trials and a study into the use of heart rate variability as a non-invasive biomarker for predicting fatigue severity in ME/CFS patients.
ME/CFS fact sheets

Accessibility
Research Digest 24/01/20

Welcome to the 39th edition, featuring a systematic review of ME/CFS randomized controlled trials and a study into the use of heart rate variability as a non-invasive biomarker for predicting fatigue severity in ME/CFS patients.
Bunnings Sausage Sizzle Raises Money for Emerge Australia

'We just wanted to do something for our daughter who was diagnosed about five years ago with sudden onset ME/CFS,' Peter and Bronwyn said. '...after considering a few different options for raising money, we thought about a Bunnings BBQ.'
Health and Wellbeing Survey

Emerge Australia published results from its first ME/CFS Health and Wellbeing Survey in 2018 and launched another survey in 2019. We plan to stay current and informed about the needs of the ME/CFS community by running an updated version of this Health and Wellbeing Survey every three years.
Disability Support Pension

The Disability Support Pension (DSP) is a Centrelink payment providing financial support if you have a physical, intellectual or psychiatric condition that stops you from working. Click here to access resources developed to assist people with ME/CFS to understand DSP and what is required to apply.
Research Digest 10/01/20

Welcome to the 38th edition, featuring a Nature paper examining blood lactate levels in ME/CFS patients whilst at rest and a paper investigating the effect of pharmaceutical intervention on NK cell cytotoxicity in ME/CFS patients compared to healthy individuals.
Research Digest 17/05/19

Welcome to the 23rd edition, featuring articles on the validation of impaired transient receptor potential melastatin 3 ion channel activity in natural killer cells from ME/CFS patients, and markers of non-coeliac wheat sensitivity in patients with ME/CFS.
What is ME/CFS?

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a complex and disabling disease that affects many parts of the body, including the brain and muscles, as well as the digestive, immune and cardiac systems, among others.
National Disability Insurance Scheme

The National Disability Insurance Scheme (NDIS) is designed to help support people with disability. Click here to access resources developed to assist people with ME/CFS to understand the NDIS and what is required to apply.
Privacy Policy

Emerge Australia's privacy policy